Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Prevention of Transfusion-Associated Graft Versus Host Disease (TA-GVHD) by Photochemical Treatment of Platelet Components: Clinical Experience in Routine Use.

Jean Claude Osselaer, MD, JD, Chantal Doyen, MD, Carlos Graux, MD, Christian Chatelain, MD, Anne Sonnet, MD, Michele Jacquet, MS, Jin Sying Lin, PhD, Laurence Corash, MD, Andre Bosly, MD, PhD

Blood (2007) 110 (11): 2885.

https://doi.org/10.1182/blood.V110.11.2885.2885

Published: 2007

Journal Articles

Cytokines in Platelet Components Associated with Acute Transfusion Reactions: The Role of sCD40L.

Laurence Corash, MD, Fabrice Cognasse, PhD, Jean-Claude Osselaer, MD, JD, Natalie Messe, Maryse Van Hooydonk, RN, Olivier Garraud, MD, PhD

Blood (2006) 108 (11): 952.

https://doi.org/10.1182/blood.V108.11.952.952

Published: 2006

Journal Articles

Release of Immune Modulation Factors from Platelet Concentrates during Storage after Photochemical Pathogen Inactivation.

Laurence Corash, MD, Fabrice Cognasse, PhD, Jean-Claude Osselaer, MD, JD, Natalie Messe, Olivier Garraud, MD, PhD

Blood (2006) 108 (11): 941.

https://doi.org/10.1182/blood.V108.11.941.941

Published: 2006

Journal Articles

Routine Use of Platelet Components Prepared with Photochemical Treatment (INTERCEPT Platelets™): Impact on Clinical Outcomes and Resources.

Jean Claude Osselaer, MD, JD, Chantal Doyen, MD, Natalie Messe, Maryse Van Hooydonk, RN, Michele Jacquet, MS, Anne Sonnet, MD, Andre Bosly, MD, PhD, Jocelyne Flament, MD, Laurence Corash, MD

Blood (2005) 106 (11): 429.

https://doi.org/10.1182/blood.V106.11.429.429

Published: 2005

Journal Articles

Routine Use of Platelet Components Prepared with Photochemical Treatment (INTERCEPT Platelets) : Impact on Clinical Outcomes and Costs.

Jean Claude Osselaer, MD, JD, Chantal Doyen, MD, Anne Sonet, MD, Maryse Van Hooydonk, RN, Edith Goossenaerts, RN, Christian Chatelain, MD, Andre Bosly, MD, PhD, Laurence Corash, MD

Blood (2004) 104 (11): 3629.

https://doi.org/10.1182/blood.V104.11.3629.3629

Published: 2004

NARROW

Prevention of Transfusion-Associated Graft Versus Host Disease (TA-GVHD) by Photochemical Treatment of Platelet Components: Clinical Experience in Routine Use.

Cytokines in Platelet Components Associated with Acute Transfusion Reactions: The Role of sCD40L.

Release of Immune Modulation Factors from Platelet Concentrates during Storage after Photochemical Pathogen Inactivation.

Routine Use of Platelet Components Prepared with Photochemical Treatment (INTERCEPT Platelets™): Impact on Clinical Outcomes and Resources.

Routine Use of Platelet Components Prepared with Photochemical Treatment (INTERCEPT Platelets) : Impact on Clinical Outcomes and Costs.

Email alerts

ASH Publications

American Society of Hematology

Prevention of Transfusion-Associated Graft Versus Host Disease (TA-GVHD) by Photochemical Treatment of Platelet Components: Clinical Experience in Routine Use.

Cytokines in Platelet Components Associated with Acute Transfusion Reactions: The Role of sCD40L.

Release of Immune Modulation Factors from Platelet Concentrates during Storage after Photochemical Pathogen Inactivation.

Routine Use of Platelet Components Prepared with Photochemical Treatment (INTERCEPT Platelets™): Impact on Clinical Outcomes and Resources.

Routine Use of Platelet Components Prepared with Photochemical Treatment (INTERCEPT Platelets) : Impact on Clinical Outcomes and Costs.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only